Viewing Study NCT00198393


Ignite Creation Date: 2025-12-25 @ 1:06 AM
Ignite Modification Date: 2026-01-25 @ 1:41 PM
Study NCT ID: NCT00198393
Status: COMPLETED
Last Update Posted: 2010-04-30
First Post: 2005-09-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Phase 2 Study of 3 Therapeutic Modalities in PS 2/3 Patients With NSCLC Stage IIIB/IV
Sponsor: Intergroupe Francophone de Cancerologie Thoracique
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Carcinoma, Non-Small-Cell Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IIIB/IV NSCLC View
None patients with performance status 2 or 3. View